These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20220595)

  • 1. Comorbidity of cognitive and mood disorders: furthering the understanding of heterogeneity.
    Kales HC
    Am J Geriatr Psychiatry; 2010 Apr; 18(4):277-80. PubMed ID: 20220595
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment and treatment of cognitive impairments in patients with affective disorders].
    Miskowiak K; Gjerullf-Hansen C; Jensen M; Nielsen S; Ott C
    Ugeskr Laeger; 2019 Nov; 181(45):. PubMed ID: 31791452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric reduction of cerebellum associated with cognitive, affective and behavioral changes.
    da Silva RO; Cheniaux E; Mezzasalma MA
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):E21. PubMed ID: 22772683
    [No Abstract]   [Full Text] [Related]  

  • 4. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients.
    Valentine AD; Meyers CA
    Cancer; 2001 Sep; 92(6 Suppl):1694-8. PubMed ID: 11598889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Affective symptoms: influence on memory disorders].
    Lebert F; Thomas-Anterion C; Letortu O
    Therapie; 1997; 52(5):507-8. PubMed ID: 9501588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperventilation syndrome and autonomic dystonia (review of the literature)].
    Moldovanu IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(5):100-3. PubMed ID: 1654684
    [No Abstract]   [Full Text] [Related]  

  • 7. [An impact of pronoran on cognitive and affective disorders in Parkinson's disease].
    Pilipovich AA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(4):41-7. PubMed ID: 15875942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electroconvulsive therapy effective and safe in 55 patients aged 56 years and older with mood disorders and physical comorbidity].
    van Waarde JA; Stek ML
    Ned Tijdschr Geneeskd; 2001 Sep; 145(35):1693-7. PubMed ID: 11561488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive and emotional disorders in multiple sclerosis. Can a management strategy be envisioned?].
    Pelletier J; Benoit N; Montreuil M; Habib M
    Pathol Biol (Paris); 2000 Mar; 48(2):121-31. PubMed ID: 10815288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. War Related Illness and Injury Study Center (WRIISC): a multidisciplinary translational approach to the care of Veterans with chronic multisymptom illness.
    Lange G; McAndrew L; Ashford JW; Reinhard M; Peterson M; Helmer DA
    Mil Med; 2013 Jul; 178(7):705-7. PubMed ID: 23820341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stress, asthenia and cognitive disorders].
    Vasenina EE; Gankina OA; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(5):23-29. PubMed ID: 35611896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmotor symptoms of Parkinson's disease.
    Zesiewicz TA; Sullivan KL; Hauser RA
    Expert Rev Neurother; 2006 Dec; 6(12):1811-22. PubMed ID: 17181428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cognitive and affective pattern in posterior fossa strokes in children: a case series.
    Kossorotoff M; Gonin-Flambois C; Gitiaux C; Quijano S; Boddaert N; Bahi-Buisson N; Barnerias C; Dulac O; Brunelle F; Desguerre I
    Dev Med Child Neurol; 2010 Jul; 52(7):626-31. PubMed ID: 20370817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distress proneness and cognitive decline in a population of older persons.
    Wilson RS; Bennett DA; Mendes de Leon CF; Bienias JL; Morris MC; Evans DA
    Psychoneuroendocrinology; 2005 Jan; 30(1):11-7. PubMed ID: 15358438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly progressive behavioral changes and parkinsonism in a 68-year-old man.
    Kleiner-Fisman G; Lang AE; Bergeron C; Burn DJ; Paviour DC
    Mov Disord; 2004 May; 19(5):534-43. PubMed ID: 15133817
    [No Abstract]   [Full Text] [Related]  

  • 16. Parkinson's disease: a review of non-motor symptoms.
    Rana AQ; Ahmed US; Chaudry ZM; Vasan S
    Expert Rev Neurother; 2015 May; 15(5):549-62. PubMed ID: 25936847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Algorithms for the treatment of affective illness, primary disorder of vigilance, and task-dependent attention disorders (learning disabilities) in children and adolescents.
    Weinberg WA; Schraufnagel CD; Harper CR; Brumback RA
    J Child Neurol; 1996 May; 11(3):220-7. PubMed ID: 8734027
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurocognitive impairment and dementia in mood disorders.
    Pfennig A; Littmann E; Bauer M
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):373-82. PubMed ID: 18070839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic solvent exposure, mood disorders, and cancer risk. An hypothesis.
    Frentzel-Beyme R
    Med Lav; 1995; 86(3):284-6. PubMed ID: 7565295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.